Dermatology
Calling for submissions for the 2022 volume for the following article types: Original Research, Study Characteristics, Clinical Studies, Systematic Reviews, Reviews, Mini Reviews, Case Series, and Commentaries
In the Dermatology section, we consider for publication the latest advances in:
|
Acne |
Melanoma |
|
Alopecia |
Nail lichen planus |
|
Alopecia areata |
Nail tumors |
|
Androgenic alopecia |
Nails psoriasis |
|
Basal cell carcinoma |
Non-melanoma skin cancer |
|
Brittle nails |
Onychomycosis |
|
Eczema |
Psoriais |
|
Hair loss |
Rosacea |
|
Lichen planus |
Annals of Medicine
Q1 Impact Factor Best Quartile
Two-Year Impact Factor 4.709
Five-Year Impact Factor 4.554
CiteScore 7.2
PubMed Central® and MEDLINE® Indexed
Meet the Section Editor
Shari R Lipner, MD, Phd, Department of Dermatology, Weill Cornell Medicine, New York, USA
Dr Lipner is an Associate Professor of Clinical Dermatology, Director of the Nail Division and an Associate Attending Physician at the New York-Presbyterian Hospital/Weill Cornell Medical Center. She completed her undergraduate studies at Dartmouth College where she obtained a BA in Chemistry. Dr Lipner undertook both her MD and PhD at Albert Einstein College of Medicine and her Residency training in Dermatology at the New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr Lipner is a member of the American Academy of Dermatology, Women's Dermatologic Society and Countril for Nail Disorders and is also the President of the Dermatologic Society of Greater New York. Dr Lipner is board certified in Dermatology and has a wide range of clinical experience in the diagnosis and management of skin disorders, She is an expert in nail disorders - including fungal diseases and nail tumors. Dr Lipner has authored over 170 peer-reviewed publications, numerous book chapters, lectures nationwide and is frequently sought out by the media for her expertise.
Why is Annals of Medicine the best publication for your research?
|
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership; |
|
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas; |
|
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process; |
|
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact. |
Editing Services
To help improve your manuscript and prepare it for submission, Taylor & Francis provides a range of editing services such as English Language Editing, which will ensure that your article is free of spelling and grammar errors, Translation, and Artwork Preparation.